207 related articles for article (PubMed ID: 24452079)
1. Lupus vasculopathy: Diagnostic, pathogenetic and therapeutic considerations.
Gonzalez-Suarez ML; Waheed AA; Andrews DM; Ascherman DP; Zeng X; Nayer A
Lupus; 2014 Apr; 23(4):421-7. PubMed ID: 24452079
[TBL] [Abstract][Full Text] [Related]
2. Pauci-immune necrotizing and crescentic glomerulonephritis in a patient with systemic lupus erythematosus.
Fayaz A; Pirson Y; Cosyns JP; Yango J; Lambert M
Clin Nephrol; 2008 Apr; 69(4):290-3. PubMed ID: 18397704
[TBL] [Abstract][Full Text] [Related]
3. [Case of lupus vasculopathy associated with lupus nephritis class IV-G (A)].
Eguchi E; Shimazu K; Takaori K; Nishiguchi K; Mori K; Yorifuji S; Murakami T; Koshikawa M; Tanaka A; Kuwahara T
Nihon Jinzo Gakkai Shi; 2010; 52(2):147-53. PubMed ID: 20415236
[TBL] [Abstract][Full Text] [Related]
4. Thrombotic microangiopathic hemolytic anemia in a patient with SLE: diagnostic difficulties.
Shah AA; Higgins JP; Chakravarty EF
Nat Clin Pract Rheumatol; 2007 Jun; 3(6):357-62. PubMed ID: 17538567
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil in the treatment of lupus vasculopathy.
Rathi M; Nada R
Lupus; 2014 Oct; 23(11):1217-8. PubMed ID: 24899638
[No Abstract] [Full Text] [Related]
6. Severe multiorganic flare of systemic lupus erythematosus successfully treated with rituximab and cyclophosphamide avoiding high doses of prednisone.
Gonzalez-Echavarri C; Pernas B; Ugarte A; Ruiz-Irastorza G
Lupus; 2014 Mar; 23(3):323-6. PubMed ID: 24531426
[TBL] [Abstract][Full Text] [Related]
7. Modern therapeutic strategies for paediatric systemic lupus erythematosus and lupus nephritis.
Marks SD; Tullus K
Acta Paediatr; 2010 Jul; 99(7):967-74. PubMed ID: 20222881
[TBL] [Abstract][Full Text] [Related]
8. Hydroxychloroquine-induced phospholipidosis in a case of SLE: the wolf in zebra clothing.
Khubchandani SR; Bichle LS
Ultrastruct Pathol; 2013 Apr; 37(2):146-50. PubMed ID: 23573895
[TBL] [Abstract][Full Text] [Related]
9. Posterior reversible encephalopathy syndrome in Korean patients with systemic lupus erythematosus: risk factors and clinical outcome.
Jung SM; Moon SJ; Kwok SK; Ju JH; Park KS; Park SH; Kim HY
Lupus; 2013 Aug; 22(9):885-91. PubMed ID: 23846231
[TBL] [Abstract][Full Text] [Related]
10. Intensive short-term treatment with rituximab, cyclophosphamide and methylprednisolone pulses induces remission in severe cases of SLE with nephritis and avoids further immunosuppressive maintenance therapy.
Roccatello D; Sciascia S; Rossi D; Alpa M; Naretto C; Baldovino S; Menegatti E; La Grotta R; Modena V
Nephrol Dial Transplant; 2011 Dec; 26(12):3987-92. PubMed ID: 21385860
[TBL] [Abstract][Full Text] [Related]
11. Catastrophic Anti-Phospholipid Syndrome in Systemic Lupus Erythematosus: A Tsunami in the Ocean.
Dorji T; Hegde A; Asturkar V; Yangzom S; Bhanu K
J Assoc Physicians India; 2022 Apr; 70(4):11-12. PubMed ID: 35443434
[TBL] [Abstract][Full Text] [Related]
12. Recovery of both acute massive pulmonary hemorrhage and acute renal failure in a systemic lupus erythematosus patient with lupus anticoagulant by the combined therapy of plasmapheresis plus cyclophosphamide.
Huang DF; Tsai ST; Wang SR
Transfus Sci; 1994 Sep; 15(3):283-8. PubMed ID: 10155546
[TBL] [Abstract][Full Text] [Related]
13. Infantile systemic lupus erythematosus presenting with pulmonary hemorrhage.
Kreindler J; Ellis D; Vats A; Kurland G; Ranganathan S; Moritz ML
Pediatr Nephrol; 2005 Apr; 20(4):522-5. PubMed ID: 15717168
[TBL] [Abstract][Full Text] [Related]
14. A case of lupus vasculopathy presenting favorable renal outcome.
Ishizaki Y; Aizawa A; Ochiai S; Minakawa A; Miyauchi S; Umekita K; Sato Y; Ogawa Y; Kushida Y; Okayama A; Uesugi N; Fujimoto S
CEN Case Rep; 2020 Feb; 9(1):74-80. PubMed ID: 31863345
[TBL] [Abstract][Full Text] [Related]
15. Immunosuppressive treatment of the glomerulonephritis of systemic lupus.
Faedda R; Palomba D; Satta A; Pirisi M; Tanda F; Bartoli E
Clin Nephrol; 1995 Dec; 44(6):367-75. PubMed ID: 8719548
[TBL] [Abstract][Full Text] [Related]
16. Pediatric lupus nephritis: more options, more chances?
Vachvanichsanong P; McNeil E
Lupus; 2013 May; 22(6):545-53. PubMed ID: 23629826
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of antiphospholipid antibodies following cyclophosphamide therapy in patients with systemic lupus erythematosus.
Vlachoyiannopoulos PG; Toya SP; Katsifis G; Zintzaras E; Tzioufas AG; Moutsopoulos HM
J Rheumatol; 2008 Sep; 35(9):1768-75. PubMed ID: 18634157
[TBL] [Abstract][Full Text] [Related]
18. [Renal and cerebral infarctions in a patient with systemic lupus erythematosus without antiphospholipid antibodies].
Suwabe H; Moriuchi J; Hoshina Y; Iwata Y; Ichikawa Y; Arimori S
Ryumachi; 1993 Aug; 33(4):335-40. PubMed ID: 8235916
[TBL] [Abstract][Full Text] [Related]
19. [Renal vascular lesion and microangiopathic hemolytic anemia in systemic lupus erythematosus].
Gnocchi CA; Yaryour C; Kohan A; De Rosa G; Nadal M
Medicina (B Aires); 1997; 57(2):200-4. PubMed ID: 9532830
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
